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The new work from Shan and
colleagues demonstrates the expanding
reach of molecular dynamics simulations
and sets the stage for future investiga-
tions of EGFR regulation, its oncogenic
activation, and inhibitor binding proper-
ties. For example, it will be interesting to
know what effect inclusion of Mg2+ and
ATP in the molecular dynamics calcula-
tions has on the observed conformational
rearrangements. Additionally, the present
simulations do not reveal the transition to
the inactive conformation targeted by
lapatinib. Though it may be no small
matter to extend the simulation timescale
sufficiently to observe this transition, it will
be of interest to computationally charac-
terize the relative stability of the active,
disordered, and fully inactive states.
This study also provides a few testable
hypotheses that may move the field
forward. For instance, if different acti-
vating mutations stabilize the active statevia distinct mechanisms, one might ex-
pect that, in combination, theywould yield
higher levels of activity, further shifting the
equilibrium toward dimerization. Finally,
the prediction that phosphorylation of
Tyr845 in the EGFR activation loop acti-
vates the kinase and stabilizes the EGFR
dimer may motivate the field to re-
examine the role of this phosphorylation
event in EGFR signaling.REFERENCES
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Geneticists have long sought to identify the genetic changes that made us human, but pinpointing
the functionally relevant changes has been challenging. Two papers in this issue suggest that
partial duplication of SRGAP2, producing an incomplete protein that antagonizes the original,
contributed to human brain evolution.Humans differ from the other great apes in
manyways, oneof themoreobviousbeing
our larger, more complex brains. These
human-specific characteristics have
evolved in the last 6–7 million years since
we split from our common ancestor with
chimpanzees and bonobos. We can
catalog the phenotypic differences
between humans and other great apes,
and in some cases, we can determine
when they evolved, using evidence inthe fossil record. Brain size increased
throughout this period, although unevenly
(Figure 1A and 1B), but fossil details of
internal brain structure are sparse. In a
complementary way, we can catalog the
genetic differences between humans
and chimpanzees from their genome
sequences (Chimpanzee Sequencing
and Analysis Consortium, 2005) and
identify which differences arose on the
human lineage by comparison with anoutgroup—a species external to the
chimpanzee-human branch, such as
gorilla (Scally et al., 2012). But there are
around 20 million genetic changes that
are specific to humans, most of which
probably have no functional impact what-
soever. How do we pick out the few func-
tionally relevant changes and link them
to their phenotypic consequences? Two
papers in this issue of Cell now show one
way that this can be accomplished149, May 11, 2012 ª2012 Elsevier Inc. 737
Figure 1. Evolutionary Context of SRGAP2 Duplications on the
Human Lineage
(A–D) The vertical axis shows evolutionary time from the present (0, bottom) to
7 million years ago (top). Horizontal dotted lines represent times of SRGAP2
duplications with their uncertainty indicated by gray shading.
(A) Brain volume estimates of fossils and living humans, colored according to
genus.
(B) Timescales of genera thought to include human ancestors.
(C) Sequence of duplication events of SRGAP2 copies.
(D) Inferred SRGAP2 activity as a consequence of duplication of antagonistic
paralogs and the decay of SRGAP2B.
(E) Levels of protein (schematic) and copy number of paralogs in modern
humans.(Charrier et al., 2012; Dennis
et al., 2012). The authors char-
acterize a series of partial
duplications of the single
ancestral SRGAP2 gene.
They make a strong case for
the duplicates leading to
a higher density of spines on
dendritic cells in the brain
and contributing to the neote-
nous development character-
istic of humans.
How do you sift through 20
million genetic differences? A
good starting point is the
subset of changes that have
major effects on protein-
coding genes, which includes
duplications and deletions. A
previous systematic survey
of such copy number changes
in great apes had identified
140 events that are specific
to the human lineage (Fortna
et al., 2004), including several
that are implicated in neuronal
function. These should be en-
riched for functionally impor-
tant changes. Among them
was SRGAP2, which was
shown in mice to regulate
neuronal migration and mor-
phology (Guerrier et al.,
2009). SRGAP2was therefore
an excellent candidate for
more detailed investigation
of the link between a geneticchange and evolution of the human brain.
Investigations of gene duplicates (i.e.,
paralogs) can face substantial obstacles.
Copies recently duplicated remain similar
in sequence—almost as similar as
alleles—and often confuse genome
assemblies; indeed, the SRGAP2 gene
family was grossly misassembled in the
human reference sequence. Now, Dennis
et al. (2012) present an approach to
characterize the paralogs that should
be widely applicable: use DNA from
a haploid source, a complete hydatidiform
mole (the product of fertilization of an
enucleated oocyte by a single sperm) in
which there are no allelic variants to
confound assembly, and sequence large-
insert clones. This allows the authors
to identify four copies: the parental
SRGAP2A and its three duplicates
SRGAP2B–D, and also to infer the order738 Cell 149, May 11, 2012 ª2012 Elsevier Inof the duplication events, A > B > C > D,
with C and D independently derived from
B (Figure 1C). These findings are fully
consistent with the less detailed con-
clusions of the accompanying study
(Charrier et al., 2012). Furthermore, com-
parisons of the SRGAP2 sequences
suggest that the duplication events
occurred 3.4, 2.4, and 1.0 million
years ago. The first event duplicated only
9 of the 22 exons, truncating SRGAP2 in
its F-BAR domain; therefore, all of the
other duplicated copies are also trun-
cated, with key functional consequences.
The duplicates are all expressed, and,
given their similarity, sorting out their
specific roles is challenging. The first
simplification comes because there is an
additional deletion within SRGAP2D,
removing exons 2 and 3; this, together
with its absence from some individuals inc.the general population, sug-
gests that it is unlikely to play
any important role (Figure 1E).
Interest thus focuses on
SRGAP2B and C, which are
extremely similar in sequence.
Their expression patterns are
also similar, but again there
are simplifying factors: the
level of SRGAP2B transcripts
is low, and it is also absent
from some normal indi-
viduals (Figure 1E). Thus, the
main player is SRGAP2C, and
its interaction with SRGAP2A.
This cannot have always
been true during the evolution
of humans; later in this
Preview, we will discuss the
more important role that
SRGAP2B must have played
earlier in evolutionary history.
Previouswork on themouse
orthologofSRGAP2A (srGAP2
or Srgap2) had shown that it
induced filipodia formation in
the developing cortex through
its F-BAR domain; in addition,
decreasing the levels of
SRGAP2A reduced axonal
and dendritic branching and
increased the rate of neuronal
migration (Guerrier et al.,
2009). Now, Charrier and col-
leagues (2012) use mouse
and cultured cell models to
understand the functionalconsequences of the human-specific
SRGAP2 duplications. The authors further
characterize the phenotypes resulting
from Srgap2 knockdown or knockout
and compare them with the effects
of SRGAP2C expression. Srgap2 knock-
down leads to neurons with increased
densities of immature-looking dendritic
spines in juveniles. Knockout mice are
viable even as homozygotes, retaining
10% of Srgap2 expression, and
show continued growth of spine heads
during development, with the result that
spine head size in adults is close to wild-
type, but spines are more numerous and
necks are longer. SRGAP2C can dimerize
with SRGAP2A through its truncated F-
BAR domain and decrease SRGAP2A
activity. Strikingly, the simple conclusion
is that SRGAP2C expression closely
mimics the Srgap2 knockdown and
knockout phenotypes in almost all of the
characteristics examined. In summary,
the functional studies suggest that
SRGAP2C, by reducing SRGAP2A acti-
vity, contributes to human-like features,
including extended brain development—
neoteny—and cell structure in the
neocortex.
In humans, the phenotypes associated
with natural loss-of-function or duplica-
tion variants of SRGAP2A and C are of
great interest. Particularly relevant is
a balanced translocation disrupting one
copy of SRGAP2A in a 5-year-old girl
with symptoms including intellectual
disability and seizures (Saitsu et al.,
2011). Loss or gain specific to SRGAP2C
has not yet been reported, but Dennis
and colleagues find large duplications
affecting numerous genes, including
SRGAP2C—predicted to increase
SRGAP2A antagonism—in both one
control and three patients with intellec-
tual disability and/or autism spectrum
disorder. Further surveys of human vari-
ants and their detailed phenotypes,
particularly SRGAP2C deletions, should
be highly informative.
These conclusions have several impli-
cations for our thinking about human
evolution. The duplications would have
had immediate and perhaps substan-tial phenotypic effects (Figure 1D).
SRGAP2B, the progenitor of SRGAP2C,
must have been an active antagonist at
the time of its duplication 3.4 million years
ago, and SRGAP2 activity would have
reached a minimum after the SRGAP2C
duplication 2.4 million years ago (Fig-
ure 1D). These duplications would have
occurred in Australopithecus species
(Figures 1B and 1C). Did they have
consequences for gross brain anatomy
that might be recognized in rare fossil
endocasts, e.g., Dart (1925) (mouse
models might be informative here),
and did they contribute to the develop-
ment and behavior of these species
documented by paleontologists? Intrigu-
ingly, the use of recognizable stone
tools began about 2.5 million years ago
(Jobling et al., 2004), and brain size
started to increase soon after (Figure 1A),
but it is difficult to test for a direct link.
Neoteny has long been recognized as
a human characteristic (Bufill et al.,
2011), and now we can begin to under-
stand its genetic and developmental
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